Clinical trial reportAnnals of the rheumatic diseasesPublished
Inhibition of structural damage progression with the selective interleukin-23 inhibitor guselkumab in participants with active PsA: results through week 24 of the phase 3b, randomised, double-blind, placebo-controlled APEX study
Regional connection
Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, with Drexel University linked by the institution reference. Affiliation source
- Counties
- Montgomery County, Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Annals of the rheumatic diseases
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Arthritis, Psoriatic; Disease Progression; Antirheumatic Agents; Antibodies, Monoclonal; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Adult; Middle Aged; Female; Male
- PubMed ID
- 40962616
- Added to directory
- Source checked